Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients (NCT04939090)

🧪 Interventions in This Study

• Olanzapine (DRUG)
• Megestrol Acetate (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (293 Sites)

Showing the first 25 of 293 sites.

• Arizona Center for Cancer Care - Gilbert — Gilbert, Arizona
• CTCA at Western Regional Medical Center — Goodyear, Arizona
• Arizona Center for Cancer Care-Peoria — Peoria, Arizona
• Arizona Center for Cancer Care - Phoenix — Phoenix, Arizona
• Arizona Center for Cancer Care - Osborn — Scottsdale, Arizona
• Arizona Center for Cancer Care - Scottsdale — Scottsdale, Arizona
• Arizona Center for Cancer Care-Surprise — Surprise, Arizona
• NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro — Jonesboro, Arkansas
• Epic Care-Dublin — Dublin, California
• Epic Care Partners in Cancer Care — Emeryville, California
• Washington Hospital — Fremont, California
• Contra Costa Regional Medical Center — Martinez, California
• Bay Area Tumor Institute — Oakland, California
• Zuckerberg San Francisco General Hospital — San Francisco, California
• Dominican Santa Cruz Hospital — Santa Cruz, California
• Epic Care Cyberknife Center — Walnut Creek, California
• Rocky Mountain Cancer Centers-Aurora — Aurora, Colorado
• Rocky Mountain Cancer Centers-Boulder — Boulder, Colorado
• Rocky Mountain Cancer Centers - Centennial — Centennial, Colorado
• Rocky Mountain Cancer Centers-Midtown — Denver, Colorado
• Rocky Mountain Cancer Centers-Rose — Denver, Colorado
• Mountain Blue Cancer Care Center - Swedish — Englewood, Colorado
• Rocky Mountain Cancer Centers - Swedish — Englewood, Colorado
• Grand Valley Oncology — Grand Junction, Colorado
• Rocky Mountain Cancer Centers-Lakewood — Lakewood, Colorado

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Advanced Malignant Solid Neoplasm

• Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer — New Brunswick, New Jersey
• Physical Activity With or Without Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Locally Advanced, Metastatic, or Recurrent Cancer — Houston, Texas
• Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic — Houston, Texas
• Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin — Duarte, California
• Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors — Houston, Texas
• Testing the Sequential Combination of the Anti-cancer Drugs Olaparib Followed by Adavosertib (AZD1775) in Patients With Advanced Solid Tumors With Selected Mutations and PARP Resistance, STAR Study — Houston, Texas

Explore by condition: All Advanced Malignant Solid Neoplasm clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.